Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Author(s): Ruxi Tong, Tianmin Wu and Jinshui Chen*

DOI: 10.2174/1871530323666230501151924

DownloadDownload PDF Flyer Cite As
Chinese Medicine Supplementing Qi and Activating Blood Circulation Relieves the Progression of Diabetic Cardiomyopathy

Page: [163 - 171] Pages: 9

  • * (Excluding Mailing and Handling)

Abstract

Background: Diabetic cardiomyopathy (DCM) is the leading cause of diabetic death as the final occurrence of heart failure and arrhythmia. Traditional Chinese medicine is usually used to treat various diseases including diabetes.

Objective: This study sought to investigate the effects of Traditional Chinese medicine supplementing Qi and activating blood circulation (SAC) in DCM.

Methods: After the construction of the DCM model by streptozotocin (STZ) injection and high glucose/fat diet feeding, rats were administered intragastrically with SAC. Then, cardiac systolic/diastolic function was evaluated by detecting left ventricular systolic pressure (LVSP), maximal rate of left ventricular pressure rise (+LVdp/dtmax), and fall (-LVdp/dtmax), heart rate (HR), left ventricular ejection fraction (EF), LV fractional shortening (FS) and left ventricular end-diastolic pressure (LVEDP). Masson’s and TUNEL staining were used to assess fibrosis and cardiomyocyte apoptosis.

Results: DCM rats exhibited impaired cardiac systolic/diastolic function manifested by decreasing LVSP, + LVdp/dtmax, -LVdp/dtmax, HR, EF and FS, and increasing LVEDP. Intriguingly, traditional Chinese medicine SAC alleviated the above-mentioned symptoms, indicating a potential role in improving cardiac function. Masson’s staining substantiated that SAC antagonized the increased collagen deposition and interstitial fibrosis area and the elevations in protein expression of fibrosisrelated collagen I and fibronectin in heart tissues of DCM rats. Furthermore, TUNEL staining confirmed that traditional Chinese medicine SAC also attenuated cardiomyocyte apoptosis in DCM rats. Mechanically, DCM rats showed the aberrant activation of the TGF-β/Smad signaling, which was inhibited after SAC.

Conclusion: SAC may exert cardiac protective efficacy in DCM rats via the TGF-β/Smad signaling, indicating a new promising therapeutic approach for DCM.

Graphical Abstract

[1]
Saeedi, P.; Petersohn, I.; Salpea, P.; Malanda, B.; Karuranga, S.; Unwin, N.; Colagiuri, S.; Guariguata, L.; Motala, A.A.; Ogurtsova, K.; Shaw, J.E.; Bright, D.; Williams, R.; Committee, I.D.F.D.A. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabet. Res. Clin. Pract., 2019, 157(107843), 107843.
[2]
Murtaza, G.; Virk, H.U.H.; Khalid, M.; Lavie, C.J.; Ventura, H.; Mukherjee, D.; Ramu, V.; Bhogal, S.; Kumar, G.; Shanmugasundaram, M.; Paul, T.K. Diabetic cardiomyopathy - A comprehensive updated review. Prog. Cardiovasc. Dis., 2019, 62(4), 315-326.
[http://dx.doi.org/10.1016/j.pcad.2019.03.003] [PMID: 30922976]
[3]
Filardi, T.; Ghinassi, B.; Di Baldassarre, A.; Tanzilli, G.; Morano, S.; Lenzi, A.; Basili, S.; Crescioli, C. Cardiomyopathy associated with diabetes: The central role of the cardiomyocyte. Int. J. Mol. Sci., 2019, 20(13), 3299.
[http://dx.doi.org/10.3390/ijms20133299] [PMID: 31284374]
[4]
Chavali, V.; Tyagi, S.C.; Mishra, P.K. Predictors and prevention of diabetic cardiomyopathy. Diabet. Metab. Syndr. Obes., 2013, 6, 151-160.
[5]
Dillmann, W.H. Diabetic cardiomyopathy. Circ. Res., 2019, 124(8), 1160-1162.
[http://dx.doi.org/10.1161/CIRCRESAHA.118.314665] [PMID: 30973809]
[6]
Jia, G.; Hill, M.A.; Sowers, J.R. Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity. Circ. Res., 2018, 122(4), 624-638.
[http://dx.doi.org/10.1161/CIRCRESAHA.117.311586] [PMID: 29449364]
[7]
Bai, L.; Li, X.; He, L.; Zheng, Y.; Lu, H.; Li, J.; Zhong, L.; Tong, R.; Jiang, Z.; Shi, J.; Li, J. Antidiabetic potential of flavonoids from traditional chinese medicine: A review. Am. J. Chin. Med., 2019, 47(5), 933-957.
[http://dx.doi.org/10.1142/S0192415X19500496] [PMID: 31248265]
[8]
Dannenberg, L.; Weske, S.; Kelm, M.; Levkau, B.; Polzin, A. Cellular mechanisms and recommended drug-based therapeutic options in diabetic cardiomyopathy. Pharmacol. Ther., 2021, 228, 107920.
[http://dx.doi.org/10.1016/j.pharmthera.2021.107920]
[9]
Wu, X.; Zhang, T.; Lyu, P.; Chen, M.; Ni, G.; Cheng, H.; Xu, G.; Li, X.; Wang, L.; Shang, H. Traditional chinese medication qiliqiangxin attenuates diabetic cardiomyopathy via activating PPARgamma. Front. Cardiovasc. Med., 2021, 8, 698056.
[10]
Wang, J.; Ma, Q.; Li, Y.; Li, P.; Wang, M.; Wang, T.; Wang, C.; Wang, T.; Zhao, B. Research progress on Traditional Chinese Medicine syndromes of diabetes mellitus. Biomed. Pharmacother., 2020, 121, 109565.
[http://dx.doi.org/10.1016/j.biopha.2019.109565]
[11]
Huang, W.; Dong, H. Coptidis rhizoma-contained traditional formulae for insomnia: A potential to prevent diabetes? Chin. J. Integr. Med., 2018, 24(10), 785-788.
[http://dx.doi.org/10.1007/s11655-018-3012-4] [PMID: 30267370]
[12]
Tian, J.; Lv, R.; Guo, W. Effect of mitochondrial dysfunction in diabetic cardiomyopathy and intervention of traditional Chinese medicine. Zhongguo Zhongyao Zazhi, 2018, 43(1), 8-14.
[PMID: 29552805]
[13]
Pang, Q.; Li, G.; Cao, F.; Liu, H.; Wei, W.; Jiao, Y. Clinical efficacy of Chinese herbs for supplementing qi and activating blood circulation combined with N-acetylcysteine in the treatment of idiopathic pulmonary fibrosis: A systematic review and network meta-analysis. PLoS One, 2022, 17(3), e0265006.
[http://dx.doi.org/10.1371/journal.pone.0265006] [PMID: 35245333]
[14]
Bi, C.; Wen, J.; Jiang, K.; Chen, S.; Wang, C.; Sun, W.; Sun, Y.; Liang, Z.; Cheng, Y.; Cheng, T.; Hu, H. Chinese drugs for supplementing Qi and activating blood circulation in preventing deep venous thrombosis after big operations in orthopaedics and traumatology. Zhongguo Zhongyao Zazhi, 2009, 34(5), 625-627.
[PMID: 19526798]
[15]
Wei, F.N.; Yang, N.Z.; Huang, X.Z. Effect of hemodialysis with Chinese herbs of supplementing qi and activating blood circulation on platelet membranous glycoprotein CD62P in patients with chronic renal failure. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih, 2007, 27(2), 106-109.
[PMID: 17342993]
[16]
Du, J.P.; Wang, C.L.; Wang, P.L.; Wang, S.L.; Gao, Z.Y.; Zhang, D.W.; Xu, H.; Shi, D.Z. Efficacy of chinese herbs for supplementing qi and activating blood circulation on patients with acute coronary syndrome and type 2 diabetes mellitus after percutaneous coronary intervention: A clinical observation. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih, 2015, 35(5), 563-567.
[PMID: 26159020]
[17]
Yin, J.J.; Yang, Y.; Wang, Q.B.; Li, Y.; Yin, D.K. Effect of chinese herbal medicine with supplement qi and activating blood circulation on tubular reabsorption function of diabetic nephropathy rats. Zhong Yao Cai, 2013, 36(6), 953-958.
[PMID: 24380284]
[18]
Liu, Z.; Zhang, Y.; Tang, Z.; Xu, J.; Ma, M.; Pan, S.; Qiu, C.; Guan, G.; Wang, J. Matrine attenuates cardiac fibrosis by affecting ATF6 signaling pathway in diabetic cardiomyopathy. Eur. J. Pharmacol., 2017, 804, 21-30.
[http://dx.doi.org/10.1016/j.ejphar.2017.03.061]
[19]
Xu, D.; Zhang, X.; Chen, X.; Yang, S.; Chen, H. Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy. Life Sci., 2020, 256, 117980.
[http://dx.doi.org/10.1016/j.lfs.2020.117980]
[20]
Frangogiannis, N.G. Cardiac fibrosis. Cardiovasc. Res., 2021, 117(6), 1450-1488.
[http://dx.doi.org/10.1093/cvr/cvaa324] [PMID: 33135058]
[21]
Kuethe, F.; Sigusch, H.; Bornstein, S.; Hilbig, K.; Kamvissi, V.; Figulla, H. Apoptosis in patients with dilated cardiomyopathy and diabetes: A feature of diabetic cardiomyopathy? Horm. Metab. Res., 2007, 39(9), 672-676.
[http://dx.doi.org/10.1055/s-2007-985823] [PMID: 17846975]
[22]
Wu, X.; Lan, X.; Hu, W.; Zhang, W.; Lai, X.; Xu, S.; Li, J.; Qiu, W.; Wang, W.; Xiao, J.; Wang, F.; Ding, Y.; Liang, L. CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer. Cancer Immunol. Immunother., 2021, 70(11), 3235-3248.
[http://dx.doi.org/10.1007/s00262-021-02931-6] [PMID: 33818637]
[23]
Yue, Y.; Meng, K.; Pu, Y.; Zhang, X. Transforming growth factor beta (TGF-beta) mediates cardiac fibrosis and induces diabetic cardiomyopathy. Diabet. Res. Clin. Pract., 2017, 133, 124-130.
[24]
Shen, N.; Li, X.; Zhou, T.; Bilal, M.U.; Du, N.; Hu, Y.; Qin, W.; Xie, Y.; Wang, H.; Wu, J.; Ju, J.; Fang, Z.; Wang, L.; Zhang, Y. Shensong yangxin capsule prevents diabetic myocardial fibrosis by inhibiting TGF-beta1/Smad signaling. J. Ethnopharmacol., 2014, 157, 161-170.
[25]
Tong, H.V.; Luu, N.K.; Son, H.A.; Hoan, N.V.; Hung, T.T.; Velavan, T.P.; Toan, N.L. Adiponectin and pro-inflammatory cytokines are modulated in Vietnamese patients with type 2 diabetes mellitus. J. Diabet. Investig., 2017, 8(3), 295-305.
[http://dx.doi.org/10.1111/jdi.12579] [PMID: 27684566]
[26]
Ju, J.; Chen, W.; Lai, Y.; Wang, L.; Wang, H.; Chen, W.J.; Zhao, X.; Ye, H.; Li, Y.; Zhang, Y. Astragalus polysaccharides improve cardiomyopathy in STZ-induced diabetic mice and heterozygous (SOD2+/-) knockout mice. Braz. J. Med. Biol. Res., 2017, 50(8), e6204.
[http://dx.doi.org/10.1590/1414-431x20176204] [PMID: 28700033]
[27]
Yu, J.; Fei, J.; Azad, J.; Gong, M.; Lan, Y.; Chen, G. Myocardial protection by Salvia miltiorrhiza Injection in streptozotocin-induced diabetic rats through attenuation of expression of thrombospondin-1 and transforming growth factor-β1. J. Int. Med. Res., 2012, 40(3), 1016-1024.
[http://dx.doi.org/10.1177/147323001204000320] [PMID: 22906274]
[28]
Zhong, Y.; Chen, L.; Li, M.; Chen, L.; Qian, Y.; Chen, C.; Wang, Y.; Xu, Y. Dangshen erling decoction ameliorates myocardial hypertrophy via inhibiting myocardial inflammation. Front. Pharmacol., 2022, 12, 725186.
[http://dx.doi.org/10.3389/fphar.2021.725186] [PMID: 35046797]
[29]
Ji, G.Q.; Chen, R.Q.; Zheng, J.X. Macrophage activation by polysaccharides from Atractylodes macrocephala Koidz through the nuclear factor-κB pathway. Pharm. Biol., 2015, 53(4), 512-517.
[http://dx.doi.org/10.3109/13880209.2014.929152] [PMID: 25327442]
[30]
Jia, G.; Whaley-Connell, A.; Sowers, J.R. Diabetic cardiomyopathy: A hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia, 2018, 61(1), 21-28.
[http://dx.doi.org/10.1007/s00125-017-4390-4] [PMID: 28776083]
[31]
Shah, M.S.; Brownlee, M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ. Res., 2016, 118(11), 1808-1829.
[http://dx.doi.org/10.1161/CIRCRESAHA.116.306923] [PMID: 27230643]
[32]
Gong, F.; Qu, R.; Li, Y.; Lv, Y.; Dai, J. Astragalus Mongholicus: A review of its anti-fibrosis properties. Front. Pharmacol., 2022, 13, 976561.
[http://dx.doi.org/10.3389/fphar.2022.976561] [PMID: 36160396]
[33]
Wang, L.; Li, Y.; Deng, W.; Dong, Z.; Li, X.; Liu, D.; Zhao, L.; Fu, W.; Cho, K.; Niu, H.; Guo, D.; Cheng, J.; Jiang, B. Cardio-protection of ultrafine granular powder for Salvia miltiorrhiza Bunge against myocardial infarction. J. Ethnopharmacol., 2018, 222, 99-106.
[http://dx.doi.org/10.1016/j.jep.2018.04.029] [PMID: 29694847]
[34]
Gao, S.L.; Hu, Z.T.; Dong, L.Y.; Fei, Z.L.; Ma, J.K.; Liu, J.Y. Clinical efficacy and mechanism of total glucosides from white paeony for radioactive liver damage. Zhongguo Zhongyao Zazhi, 2017, 42(7), 1390-1394.
[PMID: 29052404]
[35]
Jubaidi, F.F.; Zainalabidin, S.; Taib, I.S.; Hamid, Z.A.; Budin, S.B. The potential role of flavonoids in ameliorating diabetic cardiomyopathy via alleviation of cardiac oxidative stress, inflammation and apoptosis. Int. J. Mol. Sci., 2021, 22(10), 5094.
[http://dx.doi.org/10.3390/ijms22105094] [PMID: 34065781]
[36]
Wang, M.M.; Xue, M.; Yang, L.; Miao, Y.; Xu, Y.G.; Kou, N.; Qu, H.; Shi, D.Z. Chinese herbal compounds for supplementing qi and activating blood circulation combined with dual antiplatelet drugs alleviated human umbilical vein endothelial cell injury and platelet adhe sion via up-regulation of P13K/Akt pathway. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih, 2016, 36(7), 842-848.
[PMID: 30634213]
[37]
Zhang, M.X.; He, W.; Gu, P. Effects of Chinese herbal compound for supplementing qi and activating blood circulation on actin, Cx43 expressions and gap junctional intercellular communication functions of myocardial cells in patients with Coxsackie virus B 3 viral myocarditis. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih, 2010, 30(8), 880-883.
[PMID: 21038662]
[38]
Sun, S.; Yang, S.; An, N.; Wang, G.; Xu, Q.; Liu, J.; Mao, Y. Astragalus polysaccharides inhibits cardiomyocyte apoptosis during diabetic cardiomyopathy via the endoplasmic reticulum stress pathway. J. Ethnopharmacol., 2019, 238, 111857.
[http://dx.doi.org/10.1016/j.jep.2019.111857] [PMID: 30959142]
[39]
Wang, G.; Dai, G.; Song, J.; Zhu, M.; Liu, Y.; Hou, X.; Ke, Z.; Zhou, Y.; Qiu, H.; Wang, F.; Jiang, N.; Jia, X.; Feng, L. Lactone component from ligusticum chuanxiong alleviates myocardial ischemia injury through inhibiting autophagy. Front. Pharmacol., 2018, 9, 301.
[http://dx.doi.org/10.3389/fphar.2018.00301] [PMID: 29651246]
[40]
Meng, S.; Yang, F.; Wang, Y.; Qin, Y.; Xian, H.; Che, H.; Wang, L. Silymarin ameliorates diabetic cardiomyopathy via inhibiting TGF-β1/Smad signaling. Cell Biol. Int., 2019, 43(1), 65-72.
[http://dx.doi.org/10.1002/cbin.11079] [PMID: 30489003]